RANITIDINE CAN POTENTIATE THE PROKINETIC EFFECT OF ITOPRIDE AT LOW DOSES- AN IN VITRO STUDY
Abstract
Background: Gastroparesis and GERD occur concomitantly in 40 percent of the cases. Prokinetic drugs and acid blockers are employed as the main treatment modality. Ranitidine is an acid blocker with additional prokinetic activity and Itopride is a known prokinetic drug. This study was designed to observe the synergistic potentiating prokinetic effect of Ranitidine on itopride on isolated duodenum of rabbits. Methods: Ranitidine (10-5-10-3) and itopride (10-6-10-5) were added in increasing concentrations to isolated duodenum of rabbits and contractions were recorded on PowerLab Data acquisition unit AHK/214. Cumulative dose response curves were constructed. The potentiating prokinetic effect of Ranitidine on itopride was seen by using a fixed dose of ranitidine and cumulatively enhancing doses of itopride on iWorx. Results: Ranitidine and itopride produced a dose dependent reversible contraction of the isolated tissue of rabbits with ranitidine showing a max response of 0.124mV and itopride showing a maximum response of 0.131mV. Ranitidine was able to potentiate the prokinetic effect of itopride at low doses but at high dose the effect began to wane off. Conclusion: Ranitidine and itopride produce a statistically significant synergistic potentiating prokinetic effect at low doses in vitro.Keywords: Ranitidine; Itopride, Prokinetic, OutcomeReferences
References:
Leeds SG, Pescarus R, Dunst CM. Delayed Gastric Emptying and Reflux Disease. Antireflux Surgery: Springer; 2015. p. 197-203.
Hejazi RA, McCallum RW, Sarosiek I. Prokinetics in diabetic gastroparesis. Current gastroenterology reports. 2012;14(4):297-305.
Xue S, Katz P, Banerjee P, Tutuian R, Castell D. Bedtime 1. Leeds SG, Pescarus R, Dunst CM. Delayed Gastric Emptying and Reflux Disease. In: Antireflux Surgery: Springer; 2015. p.197–203.
Hejazi RA, McCallum RW, Sarosiek I. Prokinetics in diabetic gastroparesis. Curr Gastroenterol Rep 2012;14(4):297–305.
Xue S, Katz P, Banerjee P, Tutuian R, Castell D. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 2001;15(9):1351–6.
Yoon S, Lee H, Kim TE, Lee S, Chee DH, Cho JY, et al. Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers. Drug Des Devel Ther 2014;8:123–8.
Scarpellini E, Vos R, Blondeau K, Boecxstaens V, Farre R, Gasbarrini A, et al. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. Aliment Pharmacol Ther 2011;33(1):99–105.
Rahul K, Balbir S, Priyamvada S. Comparative evaluation of itopride and domperidone in gastroesophageal reflux disease. Int J Basic Clin Pharmacol 2014;3(3):437–41.
Iwanaga Y, Miyashita N, Saito T, Morikawa K, Itoh Z. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs. Jpn J Pharmacol 1996;71(2):129–37.
Huang X, Lv B, Zhang S, Fan YH, Meng LN. Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol 2012;18(48):7371–7.
Mushiroda T, Douya R, Takahara E, Nagata O. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. Drug Metab Dispos 2000;28(10):1231–7.
Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354(8):832–40.
Lembo A, Camilleri M. Chronic constipation. New England J Med. 2003;349(14):1360–8.
Aouam K, Bouida W, Ben Fredj N, Chaabane A, Boubaker H, Boukef R, et al. Severe ranitidine‐induced anaphylaxis: a case report and literature review. J Clin Pharm Ther 2012;37(4):494–6.
Doi H, Sakakibara R, Sato M, Hirai S, Masaka T, Kishi M, et al. Nizatidine ameliorates gastroparesis in Parkinson's disease: A pilot study. Mov Disord 2014;29(4):562–6.
Parkman HP, Pagano AP, Ryan JP. Ranitidine and nizatidine stimulate antral smooth muscle contractility via excitatory cholinergic mechanisms. Dig Dis Sci 1998;43(3):497–505.
Kortejärvi H, Yliperttula M, Dressman JB, Junginger HE, Midha KK, Shah VP, et al. Biowaiver monographs for immediate release solid oral dosage forms: Ranitidine hydrochloride. J Pharm Sci 2005;94(8):1617–25.
Hawwa AF, Westwood PM, Collier PS, Millership JS, Yakkundi S, Thurley G, et al. Prophylactic ranitidine treatment in critically ill children–a population pharmacokinetic study. Br J Clin Pharmacol 2013;75(5):1265–76.
Madani S, Kauffman R, Simpson P, Lehr VT, Lai ML, Sarniak A, et al. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children. J Clin Pharmacol 2014;54(2):201–5.
Tanko Y, Alladey O, Ahmed MK, Mohammed A, Musa KY. The effect of methanol leaves extract of Ficus glumosa on gastrointestinal motility and on castor oil induced diarrhea in laboratory animals. J Nat Prod Plant Resour 2012;2(3):360–7.
Chiragh S, Begum A, Karim S. Prokinetic effect of clarithromycin and azithromycin-in vitro study on rabbit duodenum. Biomedica 2006;22(2):130–4.
Chetty N, Irving HR, Coupar IM. Activation of 5‐HT3 receptors in the rat and mouse intestinal tract: a comparative study. Br J Pharmacol 2006;148(7):1012–21.
Kusano M, Hosaka H, Kawada A, Kuribayashi S, Shimoyama Y, Zai H, et al. Gastrointestinal Motility and Functional Gastrointestinal Diseases. Current pharmaceutical design. 2014;20(16):2775–82.
Zai H, Matsueda K, Kusano M, Urita Y, Saito Y, Kato H. Effect of acotiamide on gastric emptying in healthy adult humans. Eur J Clin Invest 2014;44(12):1215–21.
Iwanaga Y, Miyashita N, Morikawa K, Mizumoto A, Kondo Y, Itoh Z. A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine. Gastroenterology 1990;99(2):401–8.
Lim HC, Kim YG, Lim JH, Kim HS, Park H. Effect of itopride hydrochloride on the ileal and colonic motility in guinea pig in vitro. Yonsei Med J 2008;49(3):472–8.
Iwanaga Y, Kimura T, Miyashita N, Morikawa K, Nagata O, Itoh Z, et al. Characterization of acetylcholinesterase-inhibition by itopride. Jpn J Pharmacol 1994;66(3):317–22.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
